arrow
L

Li Wang

Wuhan University
H指数:16
被引数:893

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Updated Safety and Efficacy Results of RM-001, Autologous HBG1/2 Promoter-Modified CD34+Hematopoietic Stem and Progenitor Cells, in Treating Transfusion-Dependent β-Thalassemia

RM-001的安全性及有效性最新结果,RM-001为自体HBG1/2启动子修饰的CD34+造血干细胞和祖细胞,用于治疗输血依赖型β-地中海贫血

BLOOD
IF23.1
2024-11-050
PRE
First-in-Human Study of Autologous HBA2-Edited CD34+Hematopoietic Stem and Progenitor Cells in Alpha-Thalassemia with Constant Spring Mutation

首次人体研究:自体HBA2编辑的CD34+造血干细胞和祖细胞在常春藤突变型α地中海贫血中的应用

BLOOD
IF23.1
2024-11-050
PRE